Almond Consumption during Energy Restriction Lowers Truncal Fat and Blood Pressure in Compliant Overweight or Obese Adults
- PMID: 27807041
- DOI: 10.3945/jn.116.238444
Almond Consumption during Energy Restriction Lowers Truncal Fat and Blood Pressure in Compliant Overweight or Obese Adults
Abstract
Background: The inclusion of almonds in an energy-restricted diet has been reported both to enhance or to have no effect on weight loss. Their effects specifically on visceral body fat stores during energy restriction have not been widely examined. In addition, almond consumption has been associated with reduced blood pressure (BP), but whether this is linked to or independent of changes in body composition has to our knowledge not been examined.
Objective: We evaluated the effects of consuming almonds as part of an energy-restricted diet on body composition, specifically visceral adipose tissue (VAT) and BP, compared to a nut-free energy-restricted diet.
Methods: A randomized controlled 12-wk clinical trial of 86 healthy adults [body mass index (in kg/m2): 25-40] was conducted. Participants were randomly assigned to 1 of 2 energy-restricted (500-kcal deficit/d) diets: an almond-enriched diet (AED) (15% energy from almonds) or a nut-free diet (NFD). A linear mixed-model analysis on primary outcomes such as body weight, body fat, VAT, and BP was performed on all participants [intention-to-treat (ITT) analysis] and compliant participants (complier analysis).
Results: Body weight, truncal and total fat percentage, VAT, and systolic BP decreased after 12 wk of energy restriction in both the ITT and complier analyses (P < 0.05). The complier analysis (but not the ITT analysis) indicated a greater mean ± SEM reduction in truncal fat (AED: -1.21% ± 0.26%; NFD: -0.48% ± 0.24%; P = 0.025), total fat (AED: -1.79% ± 0.36%; NFD: -0.74% ± 0.33%; P = 0.035), and diastolic BP (AED: -2.71 ± 1.2 mm Hg; NFD: 0.815 ± 1.1 mm Hg; P = 0.029), and a greater tendency for VAT loss (AED: -8.19 ± 1.8 cm2; NFD: -3.99 ± 1.7 cm2; P = 0.09) over time in the AED group than the NFD group.
Conclusions: Moderate almond consumption by compliant overweight and obese individuals during energy restriction results in greater proportional reductions of truncal and total body fat as well as diastolic BP and hence may help to reduce metabolic disease risk in obesity. This trial was registered at clinicaltrials.gov as NCT02360787.
Keywords: almonds; blood pressure; body composition; body fat; energy restriction; nuts; obesity; visceral fat; weight loss.
© 2016 American Society for Nutrition.
Similar articles
-
Almond supplementation on appetite measures, body weight, and body composition in adults: A systematic review and dose-response meta-analysis of 37 randomized controlled trials.Obes Rev. 2024 May;25(5):e13711. doi: 10.1111/obr.13711. Epub 2024 Feb 13. Obes Rev. 2024. PMID: 38351580 Review.
-
Almonds vs. carbohydrate snacks in an energy-restricted diet: Weight and cardiometabolic outcomes from a randomized trial.Obesity (Silver Spring). 2023 Oct;31(10):2467-2481. doi: 10.1002/oby.23860. Epub 2023 Aug 24. Obesity (Silver Spring). 2023. PMID: 37621033 Clinical Trial.
-
A Comprehensive Review of Almond Clinical Trials on Weight Measures, Metabolic Health Biomarkers and Outcomes, and the Gut Microbiota.Nutrients. 2021 Jun 8;13(6):1968. doi: 10.3390/nu13061968. Nutrients. 2021. PMID: 34201139 Free PMC article. Review.
-
Effects of almond consumption on the post-lunch dip and long-term cognitive function in energy-restricted overweight and obese adults.Br J Nutr. 2017 Feb;117(3):395-402. doi: 10.1017/S0007114516004463. Epub 2017 Feb 10. Br J Nutr. 2017. PMID: 28183366 Clinical Trial.
-
A randomized trial of the effects of an almond-enriched, hypocaloric diet in the treatment of obesity.Am J Clin Nutr. 2012 Aug;96(2):249-54. doi: 10.3945/ajcn.112.037895. Epub 2012 Jun 27. Am J Clin Nutr. 2012. PMID: 22743313 Free PMC article. Clinical Trial.
Cited by
-
Chronic almond nut snacking alleviates perceived muscle soreness following downhill running but does not improve indices of cardiometabolic health in mildly overweight, middle-aged, adults.Front Nutr. 2024 Jan 8;10:1298868. doi: 10.3389/fnut.2023.1298868. eCollection 2023. Front Nutr. 2024. PMID: 38260074 Free PMC article.
-
The Cardioprotective Properties of Selected Nuts: Their Functional Ingredients and Molecular Mechanisms.Foods. 2024 Jan 11;13(2):242. doi: 10.3390/foods13020242. Foods. 2024. PMID: 38254543 Free PMC article. Review.
-
Tree Nut and Peanut Consumption and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Adv Nutr. 2023 Sep;14(5):1029-1049. doi: 10.1016/j.advnut.2023.05.004. Epub 2023 May 5. Adv Nutr. 2023. PMID: 37149262 Free PMC article. Review.
-
Perspective: Is it Time to Expand Research on "Nuts" to Include "Seeds"? Justifications and Key Considerations.Adv Nutr. 2022 Aug 1;13(4):1016-1027. doi: 10.1093/advances/nmac028. Adv Nutr. 2022. PMID: 35333288 Free PMC article. Review.
-
Are fatty nuts a weighty concern? A systematic review and meta-analysis and dose-response meta-regression of prospective cohorts and randomized controlled trials.Obes Rev. 2021 Nov;22(11):e13330. doi: 10.1111/obr.13330. Epub 2021 Sep 8. Obes Rev. 2021. PMID: 34494363 Free PMC article. Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources